• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清肿瘤标志物癌胚抗原(CEA)、甲胎蛋白(AFP)、糖类抗原15-3(CA 15-3)、组织多肽特异性抗原(TPS)和神经氨酸酶(Neu)在乳腺癌诊断中的应用

Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.

作者信息

Eskelinen M, Kataja V, Hämäläinen E, Kosma V M, Penttilä I, Alhava E

机构信息

Department of Surgery, University and University Hospital of Kuopio, Finland.

出版信息

Anticancer Res. 1997 Mar-Apr;17(2B):1231-4.

PMID:9137478
Abstract

The aim of the present study was to assess the clinical value of five serum tumour markers AFP, CA 15-3, CEA, TPS and Neu oncoprotein (p 185) in the diagnosis of breast cancer. The serum values were measured in a prospective series of patients with breast cancer (n = 233), benign breast disease (n = 176) and healthy control subjects (n = 215). The cut-off levels (90% specificity) were determined for each test. Using these cut-off levels the diagnostic sensitivity of the CEA test was 0.23, for the AFP test it was 0.16, for the CA 15-3 test 0.27, for the TPS test 0.18 and for the Neu oncoprotein test 0.19 in detecting breast cancer. Correlation coefficients (Pearson's) were statistically significant between CEA and CA 15-3, and between CA 15-3 and Neu oncoprotein measurements in breast cancer patients. In patients with benign breast disease the serum levels of AFP, CA 15-3, CEA and TPS correlated with age, being somewhat higher in older patients. Similarly, in population controls higher age correlated with higher levels of AFP, CA 15-3, Neu and TPS. In breast cancer patients there was no correlation between the age at diagnosis and any of the measured markers. The only marker statistically significantly associated with the stage of breast cancer was CA 15-3. In conclusion, our results indicate that serum CEA, AFP, CA 15-3, TPS and Neu oncoprotein are only of limited value in the diagnosis of breast cancer.

摘要

本研究的目的是评估五种血清肿瘤标志物甲胎蛋白(AFP)、癌抗原15-3(CA 15-3)、癌胚抗原(CEA)、组织多肽特异性抗原(TPS)和神经肿瘤蛋白(p 185)在乳腺癌诊断中的临床价值。对一系列前瞻性乳腺癌患者(n = 233)、乳腺良性疾病患者(n = 176)和健康对照者(n = 215)测定了血清值。确定了每项检测的临界值(特异性90%)。使用这些临界值,CEA检测在检测乳腺癌时的诊断敏感性为0.23,AFP检测为0.16,CA 15-3检测为0.27,TPS检测为0.18,神经肿瘤蛋白检测为0.19。在乳腺癌患者中,CEA与CA 15-3之间以及CA 15-3与神经肿瘤蛋白测量值之间的相关系数(Pearson相关性)具有统计学意义。在乳腺良性疾病患者中,AFP、CA 15-3、CEA和TPS的血清水平与年龄相关,老年患者的水平略高。同样,在人群对照中,年龄越大,AFP、CA 15-3、神经肿瘤蛋白和TPS的水平越高。在乳腺癌患者中,诊断时的年龄与任何测量的标志物之间均无相关性。唯一与乳腺癌分期有统计学显著相关性的标志物是CA 15-3。总之,我们的结果表明,血清CEA、AFP、CA 15-3、TPS和神经肿瘤蛋白在乳腺癌诊断中的价值有限。

相似文献

1
Serum tumour markers CEA, AFP, CA 15-3, TPS and Neu in diagnosis of breast cancer.血清肿瘤标志物癌胚抗原(CEA)、甲胎蛋白(AFP)、糖类抗原15-3(CA 15-3)、组织多肽特异性抗原(TPS)和神经氨酸酶(Neu)在乳腺癌诊断中的应用
Anticancer Res. 1997 Mar-Apr;17(2B):1231-4.
2
Clinical value of serum tumour markers TPA, TPS, TAG 12, CA 15-3 and MCA in breast cancer diagnosis; results from a prospective study.血清肿瘤标志物TPA、TPS、TAG 12、CA 15-3和MCA在乳腺癌诊断中的临床价值;一项前瞻性研究的结果
Anticancer Res. 1994 Mar-Apr;14(2B):699-703.
3
[Diagnostic value of combined detection of TPS, CA153 and CEA in breast cancer].[TPS、CA153和CEA联合检测在乳腺癌中的诊断价值]
Di Yi Jun Yi Da Xue Xue Bao. 2005 Oct;25(10):1293-4, 1298.
4
TPS and CA 15.3 serum values as a guide for treating and monitoring breast cancer patients.TPS和CA 15.3血清值作为治疗和监测乳腺癌患者的指导指标。
Anticancer Res. 1996 Mar-Apr;16(2):875-81.
5
Serum tissue polypeptide specific antigen (TPS) in breast cancer patients: comparison with CA 15.3 and CEA.乳腺癌患者血清组织多肽特异性抗原(TPS):与CA 15.3和癌胚抗原的比较
Anticancer Res. 1995 Jul-Aug;15(4):1609-11.
6
Prognostic significance of serum Her2/neu, BCL2, CA15-3 and CEA in breast cancer patients: a short follow-up.乳腺癌患者血清 Her2/neu、BCL2、CA15-3 和 CEA 的预后意义:短期随访。
Cancer Biomark. 2010;6(2):63-72. doi: 10.3233/CBM-2009-0119.
7
Clinical value of TPS, CEA and CA 15-3 in breast cancer patients.TPS、CEA和CA 15-3在乳腺癌患者中的临床价值。
Anticancer Res. 1995 Nov-Dec;15(6B):2711-6.
8
Small intestinal mucin antigen (SIMA); a novel tumour marker in colorectal cancer?
Anticancer Res. 1995 Sep-Oct;15(5B):2351-6.
9
A prospective study of tissue polypeptide specific antigen (TPS) in breast cancer diagnosis.一项关于组织多肽特异性抗原(TPS)在乳腺癌诊断中的前瞻性研究。
Anticancer Res. 1992 Nov-Dec;12(6B):2033-6.
10
Influence of cardiopulmonary resuscitation on levels of tumour markers.心肺复苏对肿瘤标志物水平的影响。
Eur J Cancer Care (Engl). 2006 Jul;15(3):252-6. doi: 10.1111/j.1365-2354.2005.00648.x.

引用本文的文献

1
Circulating Tissue Polypeptide-Specific Antigen in Pre-Diagnostic Pancreatic Cancer Samples.诊断前胰腺癌样本中的循环组织多肽特异性抗原
Cancers (Basel). 2021 Oct 23;13(21):5321. doi: 10.3390/cancers13215321.
2
A bead-based multiplexed immunoassay to evaluate breast cancer biomarkers for early detection in pre-diagnostic serum.一种基于微珠的多重免疫测定法,用于评估乳腺癌生物标志物以在诊断前血清中进行早期检测。
Int J Mol Sci. 2012 Oct 22;13(10):13587-604. doi: 10.3390/ijms131013587.
3
Growth characteristics and metastatic properties of human breast cancer xenografts in immunodeficient mice.
免疫缺陷小鼠中人乳腺癌异种移植瘤的生长特性及转移特性
Am J Pathol. 1998 May;152(5):1299-311.